rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

David Colpman

Director

Company insider

Files Form 4 as: Director, Elutia.

In numbers

Trades disclosed
9
Buys
3
Sells
0
Bought
$30K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
20 Oct 2022
Last trade
11 Jun 2026
Last filed
15 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ELUT ElutiaDirector · Biotechnology · last 11 Jun 20263 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 15 Jun 2026ELUT Elutiaoption or derivative · BiotechnologySEC FORM 4 Code A—106,393 at $0.00filing
11 Jun 2026filed 15 Jun 2026ELUT Elutiaoption or derivative · BiotechnologySEC FORM 4 Code A—106,393 at $0.00filing
17 Dec 2025filed 18 Dec 2025ELUT ElutiaBiotechnologySEC FORM 4 Bought$6,37512,500 at $0.51filing
17 Nov 2025filed 19 Nov 2025ELUT ElutiaBiotechnologySEC FORM 4 Bought$11K15,500 at $0.74filing
29 May 2025filed 2 Jun 2025ELUT Elutiaoption or derivative · BiotechnologySEC FORM 4 Code A—60,339 at $0.00filing
6 Jun 2024filed 10 Jun 2024ELUT Elutiaoption or derivative · BiotechnologySEC FORM 4 Code A—31,835 at $0.00filing
8 Jun 2023filed 12 Jun 2023ELUT Elutiaoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
15 Dec 2022filed 16 Dec 2022ELUT ElutiaBiotechnologySEC FORM 4 Bought$12K3,098 at $3.90filing
20 Oct 2022filed 24 Oct 2022ELUT Elutiaoption or derivative · BiotechnologySEC FORM 4 Code A—28,513 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

C. Randal MillsPresident and CEO · President and CEO at Elutia, filing Form 4 there in the last year
Matthew FergusonChief Financial Officer · Chief Financial Officer at Elutia, filing Form 4 there in the last year
Michelle LeRoux WilliamsChief Scientific Officer · Chief Scientific Officer at Elutia, filing Form 4 there in the last year
Kevin RakinDirector and 10% owner · Director and 10% owner at Elutia, filing Form 4 there in the last year
Guido J. NeelsDirector · Director at Elutia, filing Form 4 there in the last year